A Randomized, Double-blind, Active (Pramipexole 0.5 mg Tid) and Placebo Controlled, Study of Pramipexole Given 0.5 mg and 0.75 mg Bid Over 12-week Treatment in Early Parkinson's Disease (PD) Patients

Clinical trial NCT00402233 · COMPLETED

Trial details

NCT number: NCT00402233
Sponsor: Boehringer Ingelheim
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Parkinson Disease

Start date: 2006-11-01
Primary completion: 2008-09-01
Enrollment: 312

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.